Graney Bridget A, Wamboldt Frederick S, Baird Susan, Churney Tara, Fier Kaitlin, Korn Marjorie, McCormick Mark, Vierzba Thomas, Swigris Jeffrey J
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Anschutz Medical Campus, 12700 E 19th Ave, RC2 9th Floor, Aurora, CO, 80045-2563, USA.
Participation Program for Pulmonary Fibrosis (P3F), P3F Coordinating Center, c/o National Jewish Health, 1400 Jackson Street, F107, Denver, CO, 80206, USA.
Health Qual Life Outcomes. 2017 Jul 1;15(1):133. doi: 10.1186/s12955-017-0710-0.
Patients prescribed supplemental oxygen (O) therapy face challenges as they adjust to being constantly "tethered" to an oxygen delivery device. Informal caregivers (ICs) of patients with pulmonary fibrosis (PF) face their own, often overlooked hardships when O is brought into their home and added to their lives. Our aim was to understand the multiple effects of supplemental oxygen therapy on ICs of patients with PF.
We conducted single, semi-structured telephone interviews with twenty ICs of patients with PF who were using O for at least 8 months. We performed a qualitative, content analysis based in grounded theory to examine data across subjects.
ICs initially reacted to O with trepidation and sadness as they came to recognize the changes it would cause in the lives of their patient-loved one (PLO). ICs recognized both beneficial and negative effects of O on their PLOs. ICs also realized that O created significant changes in their own lives, including introducing new roles and responsibilities for them, altering their home environments and significantly impacting their relationships with their PLOs. Although O was a tangible and constant reminder of disease progression, over time ICs were able to adapt and accept their new lives with O.
ICs of patients with PF experience many life changes when their PLO is prescribed O. Having O prescribers anticipate and recognize these challenges provides an opportunity to give support and guidance to ICs of PF patients who require O in the hopes of limiting the negative impact of O on their lives.
Clinicaltrials.gov , registration number NCT01961362 . Registered 9 October 2013.
接受补充氧气(O)治疗的患者在适应始终“束缚”于氧气输送设备的过程中面临挑战。肺纤维化(PF)患者的非正式护理人员(IC)在氧气进入他们的家庭并融入他们的生活时,也面临着自身常常被忽视的困难。我们的目的是了解补充氧气治疗对PF患者IC的多重影响。
我们对20名使用氧气至少8个月的PF患者的IC进行了单次半结构化电话访谈。我们基于扎根理论进行了定性的内容分析,以检查各受试者的数据。
IC最初对氧气感到恐惧和悲伤,因为他们开始认识到这会给他们所照顾的患者(PLO)的生活带来变化。IC认识到氧气对其PLO既有有益影响也有负面影响。IC还意识到氧气给他们自己的生活带来了重大变化,包括为他们带来了新的角色和责任,改变了他们的家庭环境,并显著影响了他们与PLO的关系。尽管氧气是疾病进展的切实且持续的提醒,但随着时间的推移,IC能够适应并接受有氧气的新生活。
当PF患者的PLO被开具氧气处方时,IC会经历许多生活变化。让开具氧气处方的医生预见并认识到这些挑战,为向需要氧气的PF患者的IC提供支持和指导提供了机会,以期限制氧气对他们生活的负面影响。
Clinicaltrials.gov,注册号NCT01961362。2013年10月9日注册。